International Strategies for Tropical Disease Treatments - Experiences with Praziquantel - EDM Research Series No. 026
(1998; 113 pages) View the PDF document
Table of Contents
View the documentAbstract
View the documentAcknowledgments
View the documentInformation on authors
View the documentExchange rates used in the report
Open this folder and view contentsChapter 1: Policies for praziquantel*
Open this folder and view contentsChapter 2: Bayer & E. Merck: Discovery and development of praziquantel*
Open this folder and view contentsChapter 3: Shin Poong Pharmaceutical Co.: Process development in the Republic of Korea*
Open this folder and view contentsChapter 4: The Egyptian International Pharmaceutical Industries Co.: Praziquantel formulation*
Close this folderChapter 5: The international supply of praziquantel*
View the documentProducers and formulators
View the documentGlobal distribution of praziquantel
View the documentReferences
Open this folder and view contentsChapter 6: Demand for praziquantel and national distribution*
Open this folder and view contentsChapter 7: Prices and production costs of praziquantel*
View the documentOther documents in the DAP Research Series
View the documentDAP Research Series No. 26
 

References

den Besten, H.W.A., Managing Director of IDA, Letter to M.R. Reich, March 15, 1996.

den Besten, H.W.A., Managing Director of IDA, Fax to M.R. Reich, April 24, 1996.

International Dispensary Association, IDA: Worldwide Service for the Medical Sector in Developing Countries. Amsterdam: IDA, n.d.

Kim, et al., Korean Patent No. 20,271. Patent approved on January 13, 1985.

Kim, et al., “United States Patent,” US Patent No. 4,497,952. Filed July 8, 1983. Patent approved on February 5, 1985.

King, C.H., and A.A. Mahmoud, “Drugs Five Years Later: Praziquantel,” Annals of Internal Medicine 110(4):290-296, 1989.

Scrip, “Bayer’s African Launch of Praziquantel Will Adopt ‘New Approach’,” Scrip No. 581, April 13, 1981: 15.

UNICEF, “Lifeline to Children,” New York and Copenhagen: UNICEF, 1992.

UNICEF, UNICEF Annual Report, New York: UNICEF, 1993.

UNICEF Supply Division, “Essential Drugs Price List: January-June, 1995,” Copenhagen: UNICEF, 1995.

US Pharmacopoeia, National Formulary, 22 ed., Rockville, MD: United States Pharmacopoeial Convention, Inc., 1993.

World Bank, “Brazil: Endemic Diseases Control Project, Staff Appraisal Report,” Washington, D.C.: The World Bank, 1989.

World Bank, “Standard Bidding Documents for Procurement of Pharmaceuticals and Vaccines,” Washington, D.C.: The World Bank, 1993.

World Health Organization, “Guidelines on the WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce,” Adopted by the Expert Committee on Specifications for Pharmaceutical Preparations, 34th Meeting, Geneva, 29 November to 3 December 1994.

 

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: November 5, 2014